Perceptive Advisors LLC Champions Oncology, Inc. Transaction History

Perceptive Advisors LLC

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2018 Aug 14, 2018	SELL	$3.6 - $7.27 $1.32 Million - $2.67 Million	-366,973 Closed	0 $0
Q1 2018 May 15, 2018	SELL	$3.39 - $4.39 $66,332 - $85,899	-19,567 Reduced 5.06%	366,973 $1.34 Million
Q3 2017 Nov 14, 2017	BUY	$3.03 - $3.97 $1.17 Million - $1.53 Million	386,540	386,540 $1.42 Million

5.81M

3.3K

6.1K

Ticker CSBR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 13,522,400
Market Cap $53.7M
Description
Champions Oncology, Inc. develops and sells technology solutions and products to personalize the development and use of oncology drugs in the United States. Its Tumorgraft Technology Platform is an approach to personalizing cancer care based upon the implantation of human tumors in immune-deficient mice. The company, through its Tumorgraft Techn...

Get notified when there are updates to the investment portfolio of Perceptive Advisors LLC, based on Form 13F filings with the SEC.

Stay updated on Perceptive Advisors LLC with notifications on news.